UVV - Universal Corporation
NYSE
->
Consumer Defensive
->
Tobacco
Richmond,
United States
Type: Equity
UVV price evolution
UVV
| (in millions $) | 30 Jul 2024 | 31 Dec 2023 | 30 Sep 2023 | 30 Jun 2023 |
|---|---|---|---|---|
| Current assets | ||||
| Cash | $74.1 | $99.68 | $80.52 | |
| Short term investments | ||||
| Net receivables | $627.9 | $529.97 | $560.03 | |
| Inventory | $1009.03 | $1086.24 | $1100.72 | |
| Total current assets | $2013.63 | $2047.71 | $2054.79 | |
| Long term investments | $75.33 | $70.62 | $73.47 | |
| Property, plant & equipment | $395.34 | $392.93 | $393.84 | |
| Goodwill & intangible assets | $285.59 | $288.33 | $291.18 | |
| Total noncurrent assets | $820.25 | $814.06 | $832.87 | |
| Total investments | $75.33 | $70.62 | $73.47 | |
| Total assets | $2833.87 | $2861.77 | $2887.66 | |
| Current liabilities | ||||
| Accounts payable | $89.42 | $70.9 | $89.86 | |
| Deferred revenue | ||||
| Short long term debt | $375.73 | $311.85 | $370.5 | |
| Total current liabilities | $624.87 | $701.14 | $717.87 | |
| Long term debt | $639.27 | $639.89 | $640.29 | |
| Total noncurrent liabilities | $750.35 | $743.12 | $756.61 | |
| Total debt | $1015 | $951.74 | $1010.8 | |
| Total liabilities | $1375.22 | $1444.26 | $1474.48 | |
| Shareholders' equity | ||||
| Retained earnings | $1152.86 | $1119.62 | $1114.82 | |
| Other shareholder equity | -$80.25 | -$74.67 | -$72.55 | |
| Total shareholder equity | $1417.08 | $1384.19 | $1380.72 | |
| (in millions $) | 31 Dec 2023 | 31 Dec 2022 | 31 Dec 2021 | 31 Dec 2020 |
|---|---|---|---|---|
| Current assets | ||||
| Cash | $64.69 | $81.65 | $197.22 | $107.43 |
| Short term investments | ||||
| Net receivables | $585.08 | $519.82 | $489.68 | $485.97 |
| Inventory | $833.88 | $822.51 | $640.65 | $707.3 |
| Total current assets | $1802.89 | $1748.01 | $1555.36 | $1479.62 |
| Long term investments | $76.18 | $81.01 | $84.22 | $77.54 |
| Property, plant & equipment | $391.67 | $385.36 | $380.74 | $354.41 |
| Goodwill & intangible assets | $294.02 | $306.57 | $245.35 | $144.69 |
| Total noncurrent assets | $836.29 | $838.33 | $786.57 | $641.3 |
| Total investments | $76.18 | $81.01 | $84.22 | $77.54 |
| Total assets | $2639.18 | $2586.34 | $2341.92 | $2120.92 |
| Current liabilities | ||||
| Accounts payable | $89.04 | $277.35 | $140.77 | $140.26 |
| Deferred revenue | ||||
| Short long term debt | $206.97 | $192.94 | $109.19 | $87.86 |
| Total current liabilities | $441.99 | $518.72 | $293.16 | $267.4 |
| Long term debt | $642.35 | $548.16 | $537.9 | $394.66 |
| Total noncurrent liabilities | $760.24 | $682.85 | $700.34 | $564.24 |
| Total debt | $849.32 | $741.11 | $647.09 | $482.51 |
| Total liabilities | $1202.23 | $1201.58 | $993.5 | $831.64 |
| Shareholders' equity | ||||
| Retained earnings | $1136.9 | $1094.19 | $1087.66 | $1076.76 |
| Other shareholder equity | -$77.06 | -$84.31 | -$107.04 | -$151.6 |
| Total shareholder equity | $1397.09 | $1340.54 | $1307.3 | $1246.66 |
| (in millions $) | 30 Jul 2024 | 31 Dec 2023 | 30 Sep 2023 | 30 Jun 2023 |
|---|---|---|---|---|
| Revenue | ||||
| Total revenue | $821.51 | $638.48 | $517.72 | |
| Cost of revenue | $654.56 | $506.77 | $431.21 | |
| Gross Profit | $166.95 | $131.72 | $86.51 | |
| Operating activities | ||||
| Research & development | ||||
| Selling, general & administrative | $78.56 | $73.81 | $75.48 | |
| Total operating expenses | $79.49 | $76.41 | $75.48 | |
| Operating income | $87.46 | $55.31 | $11.04 | |
| Income from continuing operations | ||||
| EBIT | $83.22 | $53.62 | $12.06 | |
| Income tax expense | $14.48 | $8.44 | -$1.42 | |
| Interest expense | $15.53 | $17.05 | $15.54 | |
| Net income | ||||
| Net income | $53.22 | $28.13 | -$2.06 | |
| Income (for common shares) | $53.22 | $28.13 | -$2.06 | |
| (in millions $) | 31 Dec 2023 | 31 Dec 2022 | 31 Dec 2021 | 31 Dec 2020 |
|---|---|---|---|---|
| Revenue | ||||
| Total revenue | $2569.82 | $2103.6 | $1983.36 | $1909.98 |
| Cost of revenue | $2111.54 | $1694.67 | $1597.35 | $1553.17 |
| Gross Profit | $458.29 | $408.93 | $386 | $356.81 |
| Operating activities | ||||
| Research & development | ||||
| Selling, general & administrative | $277.21 | $240.69 | $219.79 | $222.9 |
| Total operating expenses | $277.21 | $248.61 | $238.19 | $230.44 |
| Operating income | $181.07 | $160.31 | $147.81 | $126.37 |
| Income from continuing operations | ||||
| EBIT | $185.09 | $152.99 | $141.78 | $126.82 |
| Income tax expense | $11.73 | $38.66 | $29.41 | $35.29 |
| Interest expense | $49.3 | $27.75 | $24.95 | $19.85 |
| Net income | ||||
| Net income | $124.05 | $86.58 | $87.41 | $71.68 |
| Income (for common shares) | $124.05 | $86.58 | $87.41 | $71.68 |
| (in millions $) | 31 Dec 2023 | 30 Sep 2023 | 30 Jun 2023 | 31 Mar 2023 |
|---|---|---|---|---|
| Net income | $53.22 | $28.13 | -$2.06 | $53.71 |
| Operating activities | ||||
| Depreciation | $14.83 | $14.26 | $14.75 | $14.46 |
| Business acquisitions & disposals | $3.76 | |||
| Stock-based compensation | $4.91 | $1.85 | $3.86 | $8.42 |
| Total cash flows from operations | -$57.27 | $114.42 | -$103.89 | $173.29 |
| Investing activities | ||||
| Capital expenditures | -$13.88 | -$14.28 | -$17.63 | -$15.8 |
| Investments | ||||
| Total cash flows from investing | -$13.88 | -$10.53 | -$17.63 | -$15.8 |
| Financing activities | ||||
| Dividends paid | -$19.65 | -$19.71 | -$19.4 | -$19.4 |
| Sale and purchase of stock | -$4.74 | |||
| Net borrowings | $64.78 | -$58.16 | $163.8 | -$141.55 |
| Total cash flows from financing | $45.13 | -$84.36 | $137.35 | -$164.34 |
| Effect of exchange rate | $0.45 | -$0.37 | $0 | $0.26 |
| Change in cash and equivalents | -$25.58 | $19.16 | $15.83 | -$6.59 |
| (in millions $) | 31 Dec 2023 | 31 Dec 2022 | 31 Dec 2021 | 31 Dec 2020 |
|---|---|---|---|---|
| Net income | $124.05 | $86.58 | $87.41 | $71.68 |
| Operating activities | ||||
| Depreciation | $57.3 | $52.52 | $44.73 | $38.38 |
| Business acquisitions & disposals | $3.25 | -$102.46 | -$161.75 | -$80.18 |
| Stock-based compensation | $8.42 | $6.19 | $6.11 | $5.63 |
| Total cash flows from operations | -$10.56 | $44.88 | $220.41 | $10.9 |
| Investing activities | ||||
| Capital expenditures | -$53.59 | -$40.2 | -$54.72 | -$26.68 |
| Investments | ||||
| Total cash flows from investing | -$50.35 | -$142.66 | -$217.27 | -$106.36 |
| Financing activities | ||||
| Dividends paid | -$77.39 | -$76.44 | -$75.18 | -$75.37 |
| Sale and purchase of stock | -$3.45 | -$3.05 | -$33.46 | |
| Net borrowings | $118.22 | $76.12 | $177.45 | $20.93 |
| Total cash flows from financing | $38.95 | -$16.76 | $91.39 | -$94.15 |
| Effect of exchange rate | -$1 | -$1.03 | $1.26 | -$0.51 |
| Change in cash and equivalents | -$22.96 | -$115.57 | $95.79 | -$190.13 |
News
Fundamentals
| Market cap | N/A |
|---|---|
| Enterprise value | N/A |
| Shares outstanding | N/A |
| Revenue | N/A |
|---|---|
| EBITDA | N/A |
| EBIT | N/A |
| Net Income | N/A |
| Revenue Q/Q | N/A |
| Revenue Y/Y | N/A |
| P/E ratio | N/A |
|---|---|
| EV/Sales | N/A |
| EV/EBITDA | N/A |
| EV/EBIT | N/A |
| P/S ratio | N/A |
| P/B ratio | N/A |
| Book/Share | N/A |
| Cash/Share | N/A |
| EPS | N/A |
|---|---|
| ROA | N/A |
| ROE | N/A |
| Debt/Equity | 0.86 |
|---|---|
| Net debt/EBITDA | N/A |
| Current ratio | N/A |
| Quick ratio | N/A |